METROPOLIS.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 17:59):

Stats
今日成交量	188 750
平均成交量	358 577
市值	92.92B
EPS	INR0 ( 2024-02-04 )
下一个收益日期	( INR13.40 ) 2024-05-13
Last Dividend	INR8.00 ( 2023-02-23 )
Next Dividend	INR0 ( N/A )
P/E	74.49
ATR14	INR2.64 (0.15%)

音量相关性

長: -0.18 (neutral)

短: -0.87 (strong negative)

Signal:(41.383) Neutral

Metropolis Healthcare 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Metropolis Healthcare 相关性 - 货币/商品

0.33
( neutral )

-0.03
( neutral )

0.25
( neutral )

-0.12
( neutral )

0.31
( neutral )

-0.47
( neutral )

Metropolis Healthcare 财务报表

Annual	2022
营收:	INR11.48B
毛利润:	INR8.88B (77.37 %)
EPS:	INR27.91

FY	2022
营收:	INR11.48B
毛利润:	INR8.88B (77.37 %)
EPS:	INR27.91

FY	2022
营收:	INR12.28B
毛利润:	INR9.41B (76.59 %)
EPS:	INR41.87

FY	2021
营收:	INR9.98B
毛利润:	INR7.38B (73.92 %)
EPS:	INR35.97

Financial Reports:

No articles found.

Metropolis Healthcare Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Metropolis Healthcare Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.22%) | Divividend Growth Potential Score: 3.79 - Decrease likely (24.29%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR8.00	2020-02-13
Last Dividend	INR8.00	2023-02-23
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR32.00	--
Avg. Dividend % Per Year	0.30%	--
Score	1.82	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	3.79
Div. Directional Score	3.88	--

Next Divdend (Est)
(2024-12-31)

INR0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.82

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2020	INR8.00	0.56%
2021	INR8.00	0.40%
2022	INR8.00	0.23%
2023	INR8.00	0.61%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
POLYPLEX.NS	Dividend Knight	2023-09-08	Semi-Annually	22	5.28%
JSWSTEEL.NS	Dividend Junior	2023-07-11	Annually	20	1.70%
DOLLAR.NS	Dividend Junior	2023-07-27	Annually	8	0.54%
AARVI.NS	Dividend Knight	2023-09-15	Annually	7	1.38%
SPAL.NS	Dividend Junior	2023-09-15	Sporadic	8	0.44%
MOTHERSON.NS	Dividend Junior	2023-08-11	Annually	23	0.63%
HERITGFOOD.NS	Dividend Junior	2023-08-14	Annually	23	0.44%
BIKAJI.NS	Dividend Junior	2023-06-08	Insufficient data to determine frequency	2	0.06%
RANEHOLDIN.NS	Dividend Junior	2023-07-27	Annually	21	0.95%
KOPRAN.NS	Dividend Junior	2023-09-07	Annually	5	1.18%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.108	1.500	7.85	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.122	1.500	9.75	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	8.18	1.000	8.08	8.08	[3 - 30]
operatingCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.791	1.000	0.155	0.155	[0.2 - 0.8]
operatingProfitMarginTTM	0.163	1.000	8.74	8.74	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	73.73	1.000	2.65	0	[1 - 100]
returnOnEquityTTM	0.122	2.50	9.84	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.223	1.500	4.43	0	[0 - 0.4]
operatingCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.21	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.158	1.000	8.55	0	[0.1 - 0.5]
Total Score				3.79

Metropolis Healthcare

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.